These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 38869519)
21. Palmitoylation on the carboxyl terminus tail is required for the selective regulation of dopamine D2 versus D3 receptors. Zhang X; Le HT; Zhang X; Zheng M; Choi BG; Kim KM Biochim Biophys Acta; 2016 Sep; 1858(9):2152-2162. PubMed ID: 27349735 [TBL] [Abstract][Full Text] [Related]
22. Differential induction of adenylyl cyclase supersensitivity by antiparkinson drugs acting as agonists at dopamine D1/D2/D3 receptors vs D2/D3 receptors only: parallel observations from co-transfected human and native cerebral receptors. Aloisi G; Silvano E; Rossi M; Millan MJ; Maggio R Neuropharmacology; 2011; 60(2-3):439-45. PubMed ID: 21035472 [TBL] [Abstract][Full Text] [Related]
27. D Shen Y; McCorvy JD; Martini ML; Rodriguiz RM; Pogorelov VM; Ward KM; Wetsel WC; Liu J; Roth BL; Jin J J Med Chem; 2019 May; 62(9):4755-4771. PubMed ID: 30964661 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of 50-kHz ultrasonic vocalizations by dopamine receptor subtype-selective agonists and antagonists in adult rats. Scardochio T; Clarke PB Psychopharmacology (Berl); 2013 Apr; 226(3):589-600. PubMed ID: 23192317 [TBL] [Abstract][Full Text] [Related]
29. Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism. Lane JR; Abramyan AM; Adhikari P; Keen AC; Lee KH; Sanchez J; Verma RK; Lim HD; Yano H; Javitch JA; Shi L Elife; 2020 Jan; 9():. PubMed ID: 31985399 [TBL] [Abstract][Full Text] [Related]
30. Dopamine receptors modulate cytotoxicity of natural killer cells via cAMP-PKA-CREB signaling pathway. Zhao W; Huang Y; Liu Z; Cao BB; Peng YP; Qiu YH PLoS One; 2013; 8(6):e65860. PubMed ID: 23799052 [TBL] [Abstract][Full Text] [Related]
31. Implication of dopamine D3 receptor activation in the reversion of Parkinson's disease-related motivational deficits. Carnicella S; Drui G; Boulet S; Carcenac C; Favier M; Duran T; Savasta M Transl Psychiatry; 2014 Jun; 4(6):e401. PubMed ID: 24937095 [TBL] [Abstract][Full Text] [Related]
32. Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry. Caravaggio F; Scifo E; Sibille EL; Hernandez-Da Mota SE; Gerretsen P; Remington G; Graff-Guerrero A Exp Eye Res; 2018 Oct; 175():32-41. PubMed ID: 29883636 [TBL] [Abstract][Full Text] [Related]
33. Activation of dopamine D Liu XY; Zheng LF; Fan YY; Shen QY; Qi Y; Li GW; Sun Q; Zhang Y; Feng XY; Zhu JX Am J Physiol Cell Physiol; 2022 Mar; 322(3):C327-C337. PubMed ID: 34986020 [TBL] [Abstract][Full Text] [Related]
34. The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells. de Leeuw van Weenen JE; Parlevliet ET; Maechler P; Havekes LM; Romijn JA; Ouwens DM; Pijl H; Guigas B Biochem Pharmacol; 2010 Jun; 79(12):1827-36. PubMed ID: 20138024 [TBL] [Abstract][Full Text] [Related]
35. Evidence-based practice use of quick-release bromocriptine across the natural history of type 2 diabetes mellitus. Schwartz SS; Zangeneh F Postgrad Med; 2016 Nov; 128(8):828-838. PubMed ID: 27458683 [TBL] [Abstract][Full Text] [Related]